ថេបប្លេតសម្ពាធឈាម Accuretic ឥឡូវនេះត្រូវបានប្រមូលមកវិញដោយ Pfizer

A HOLD FreeRelease 3 | eTurboNews | អ៊ីធីអិន
Avatar របស់ Linda Hohnholz
និពន្ធដោយ Linda Hohnholz

សេចក្តីសង្ខេប

 •            Products: Accuretic (quinapril hydrochloride and hydrochlorothiazide)

•             Issue: All lots are being recalled due to the presence of a nitrosamine impurity above the acceptable level for long-term use.

•             What to do: Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk. Contact your health care provider to discuss other treatment options.

កិច្ចការ

Pfizer Canada ULC is recalling all lots of Accuretic (quinapril hydrochloride and hydrochlorothiazide) medication in 10/12.5 mg, 20/12.5 mg and 20/25 mg strengths due to the presence of a nitrosamine impurity (N-nitroso-quinapril) above the acceptable level.

Accuretic is a prescription drug used to treat high blood pressure. It contains a combination of quinapril hydrochloride and hydrochlorothiazide, which both lower blood pressure.

Long-term exposure to N-nitroso-quinapril at a level above what is considered acceptable may increase the risk of cancer. We are all exposed to low levels of nitrosamines through a variety of foods (such as smoked and cured meats, dairy products and vegetables), drinking water and air pollution. This impurity is not expected to cause harm when ingested at or below the acceptable level. A person taking a drug that contains this impurity at or below the acceptable level every day for 70 years is not expected to have an increased risk of cancer.

As with previous recalls involving nitrosamine impurities, Health Canada is advising that there is no immediate risk in continuing to temporarily take the recalled Accuretic medication since the potential risk of cancer is with long-term exposure (every day for 70 years) to the nitrosamine impurity above the acceptable level. Patients can continue to take their medication as prescribed by their health care provider and do not need to return their medication to their pharmacy, but they should contact their health care provider to discuss other treatment options.

Health Canada កំពុងត្រួតពិនិត្យប្រសិទ្ធភាពនៃការហៅមកវិញ និងការអនុវត្តរបស់ក្រុមហ៊ុនចំពោះសកម្មភាពកែតម្រូវ និងបង្ការចាំបាច់ណាមួយ។ ប្រសិនបើការរំលឹកបន្ថែមណាមួយត្រូវបានចាត់ទុកថាចាំបាច់នោះ Health Canada នឹងធ្វើបច្ចុប្បន្នភាពតារាង និងជូនដំណឹងដល់ប្រជាជនកាណាដា។

ផលិតផលដែលរងផលប៉ះពាល់

ផលិតផលDINឡុតផុតកំណត់
Accuretic 10/12.5mg02237367FM95262023-08-31
Accuretic 10/12.5mg02237367FA37362022-07-31
Accuretic  10/12.5mg02237367EJ51922022-07-31
Accuretic  20/12.5mg02237368EXXXX2022-07-31
Accuretic  20/12.5mg02237368ET95112022-07-31
Accuretic  20/12.5mg02237368EF30872022-07-31
Accuretic  20/25mg02237369FA92242022-07-31
Accuretic  20/25mg02237369EA07812022-07-31

អ្វីដែលអ្នកគួរធ្វើ

•             Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk.

•             Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure.

•             If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries, and at 1-800-387-4974 for general inquiries.

អំពី​អ្នក​និពន្ធ

Avatar របស់ Linda Hohnholz

Linda Hohnholz

និពន្ធនាយកសម្រាប់ eTurboNews មានមូលដ្ឋាននៅក្នុង eTN HQ ។

ជាវប្រចាំ
ជូនដំណឹងអំពី
ភ្ញៀវ
0 យោបល់
មតិប្រតិកម្មក្នុងជួរ
មើលមតិយោបល់ទាំងអស់
0
សូមជួយផ្តល់យោបល់។x
ចែករំលែកទៅកាន់...